PPP1R3C

protein phosphatase 1 regulatory subunit 3C, the group of Protein phosphatase 1 regulatory subunits

Basic information

Region (hg38): 10:91628442-91633071

Previous symbols: [ "PPP1R5" ]

Links

ENSG00000119938NCBI:5507OMIM:602999HGNC:9293Uniprot:Q9UQK1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PPP1R3C gene.

  • not_specified (41 variants)
  • Prostate_cancer (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPP1R3C gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005398.7. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
0
missense
42
clinvar
42
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 0 42 0 0
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PPP1R3Cprotein_codingprotein_codingENST00000238994 24613
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.002640.9411257090391257480.000155
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1071661700.9770.000009832116
Missense in Polyphen4451.3380.85706660
Synonymous-0.7017567.71.110.00000429579
Loss of Function1.66612.30.4888.32e-7138

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003250.000325
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.0002310.000231
European (Non-Finnish)0.00005280.0000527
Middle Eastern0.00005440.0000544
South Asian0.0005550.000555
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acts as a glycogen-targeting subunit for PP1 and regulates its activity. Activates glycogen synthase, reduces glycogen phosphorylase activity and limits glycogen breakdown. Dramatically increases basal and insulin-stimulated glycogen synthesis upon overexpression in a variety of cell types. {ECO:0000250|UniProtKB:Q7TMB3, ECO:0000269|PubMed:8985175}.;
Pathway
Insulin resistance - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Exercise-induced Circadian Regulation;Metabolism of carbohydrates;Metabolism;Glycogen synthesis;Glycogen metabolism (Consensus)

Recessive Scores

pRec
0.159

Intolerance Scores

loftool
0.548
rvis_EVS
0.08
rvis_percentile_EVS
60.31

Haploinsufficiency Scores

pHI
0.345
hipred
Y
hipred_score
0.754
ghis
0.436

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.942

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ppp1r3c
Phenotype
muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);

Gene ontology

Biological process
glycogen metabolic process;glycogen biosynthetic process;protein dephosphorylation;regulation of phosphoprotein phosphatase activity
Cellular component
cytosol
Molecular function
protein serine/threonine phosphatase activity;protein binding;protein phosphatase regulator activity;protein phosphatase binding